• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CYBERONICS - HOUSTON PULSE GEN MODEL 106; GENERATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CYBERONICS - HOUSTON PULSE GEN MODEL 106; GENERATOR Back to Search Results
Model Number 106
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Syncope (1610); Arrhythmia (1721); Tinnitus (2103); Hypoesthesia (2352)
Event Date 03/01/2018
Event Type  Injury  
Event Description
It was reported by the anesthesiologist that patient was in clinic being induced after her baby had passed away in utero, which was not attributed to the vns.The patient received an epidural and it was reported that she had low blood pressure from the epidural and experienced syncope with vns stimulation.The physician did feel these syncope events are associated with the combination of the vns and epidural as it was stated that the clinical effects of an epidural on a patient's body have the potential for a drop in blood pressure.It was stated that the first syncope event occurred and passed.By the time the second event occurred, the patient knew it was related to the vns as she was familiar with the sensation of stimulation and the effects of stimulation.There were no lasting effects for the patient and the physician was hopeful for the patient to become pregnant again.No additional relevant information has been received to date.
 
Event Description
An article was received by the manufacturer regarding the reported event.Per the article, the patient was diagnosed with polyhydramnios.All initial levels at time of induction were unremarkable.Patient-controlled epidural analgesia (pcea) was started.No abnormalities were noted in the patient's blood pressures at two minute intervals for the first twenty minutes after placement of the epidural.Approximately 40 minutes after the initial dose, the patient experienced a loss of consciousness during placement of an intra-cervical foley bulb.The patient regained consciousness within a few seconds with no disorientation and described tinnitus immediately prior to the loss of consciousness.The patient's blood pressure was unchanged from the baseline.The initial diagnosis was that the vasovagal syncope was related to the foley bulb placement as there was no motor block or nystagmus.The patient experienced a loss of consciousness five minutes later with no obvious causative event.When the patient regained consciousness, she stated that the syncope immediately followed vns stimulation, which she recognized due to voice alterations and a "tickling pressure sensation." ephedrine was administered and continuous ecg and pulse oximetry monitoring was started.The next vns stimulation was without event.It was then decided by the medical professionals and patient to disable the vns via magnet disablement.The epidural was restarted and the labor/delivery was completed with no further episodes of syncope.The patient was not received any medications beyond the epidural infusion which might have predisposed her to the syncope.There was no clinical/laboratory evidence to suggest preeclampsia, seizure, placental abruption, or sepsis.Local anesthetic system toxicity was among the initial differential diagnoses for the syncope and the anesthetic infusion was temporarily discontinued with resuscitative supplies kept in close proximity.It was stated that during an epidural block, "a reduction in venous return can increase vagal activity, secondary to decreased right atrial filling, leading to a reduced signal output from intrinsic chronotropic stretch receptors".It was suspected that this change combined with vns stimulation led to a reversible arrhythmia and that a further increase in vagal tone from the foley bulb placement contributed to the first syncope.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PULSE GEN MODEL 106
Type of Device
GENERATOR
Manufacturer (Section D)
CYBERONICS - HOUSTON
100 cyberonics blvd
houston TX 77058
Manufacturer (Section G)
CYBERONICS - HOUSTON
100 cyberonics blvd
suite 600
houston TX 77058
Manufacturer Contact
njemile crawley
100 cyberonics blvd
suite 600
houston, TX 77058
2812287200
MDR Report Key8149367
MDR Text Key129877170
Report Number1644487-2018-02261
Device Sequence Number1
Product Code MUZ
UDI-Device Identifier05425025750061
UDI-Public05425025750061
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P970003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/12/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date07/12/2019
Device Model Number106
Device Lot Number204205
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Event Location Other
Initial Date Manufacturer Received 11/16/2018
Initial Date FDA Received12/10/2018
Supplement Dates Manufacturer Received02/16/2019
Supplement Dates FDA Received03/12/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age34 YR
-
-